Epizootic of group B Streptococcus agalactiae serotype V in DBA/2 mice

J G Geistfeld1, S H Weisbroth, E A Jansen

  • 1Taconic, Germantown, New York 12526, USA.

Laboratory Animal Science
|March 28, 1998
PubMed

Insights

Streptococcus agalactiae serotype V caused fatal septicemia in laboratory mice, originating as a kidney infection. Control involved colony eradication and disinfection, successfully preventing recurrence in new colonies.

Area of Science:

  • Veterinary Pathology
  • Microbiology
  • Infectious Diseases

Background:

  • Beta-hemolytic Streptococcus agalactiae serotype V is an emerging pathogen.
  • Serotype V infections can cause severe disease in animal models.

Purpose of the Study:

  • To identify the causative agent of a fatal epizootic in laboratory mice.
  • To characterize the clinical and pathological features of the infection.
  • To determine effective control measures.

Main Methods:

  • Bacteriological culture and identification of the causative agent.
  • Histopathological examination of affected tissues.
  • Implementation of eradication and disinfection protocols.

Main Results:

  • Streptococcus agalactiae serotype V was identified as the cause of fatal septicemia.
  • The infection originated as ascending pyelonephritis and progressed to systemic disease.
  • Microscopic lesions were observed in multiple organs, including the heart, kidneys, spleen, and liver.

Conclusions:

  • Streptococcus agalactiae serotype V poses a significant threat to laboratory mouse colonies.
  • Eradication of infected colonies, thorough disinfection, and autoclaving of equipment are critical for disease control.
  • Replacement colonies remained free of infection after implementing control measures.

Related Concept Videos